Yongyoun Hwang

Yongyoun Hwang, based in Gyeonggi-do, South Korea, is an innovative inventor with a focus on advancing medical technology through his groundbreaking work in microneedle systems. His insightful contributions to the field are reflected in his patent that aims to enhance drug delivery methods.

Latest Patents

Yongyoun Hwang holds a patent for a "Microneedle percutaneous patch containing donepezil." This invention relates to a composition designed for preparing a microneedle, involving a soluble microneedle and a microneedle percutaneous patch that incorporates this soluble microneedle. The innovation aims to provide a high drug-loading capacity and exceptional strength, allowing it to effectively deliver donepezil or its pharmaceutically acceptable salts, even from a small surface area. This design not only makes the invention economical but also minimizes skin irritation, a common issue with traditional drug delivery methods.

Career Highlights

Hwang is affiliated with Raphas Co., Ltd., where he contributes to developing cutting-edge pharmaceutical technologies. His role at the company allows him to focus on innovative solutions that address real-world medical challenges, emphasizing his commitment to improving patient care through technology.

Collaborations

During his career, Yongyoun Hwang has collaborated with esteemed colleagues, including Tae Hyung Kim and Booyong Lee. Their collective efforts reflect a synergy that fosters innovative thinking and problem-solving in the realm of medical devices and drug delivery systems.

Conclusion

Yongyoun Hwang's contributions to the field of microneedle technology represent an important advancement in drug delivery methods. His patent highlights a significant step toward more effective and user-friendly medical treatments, showcasing the potential of innovative approaches to enhance healthcare solutions.

Profile summary based on public USPTO records.